News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Non-Invasive Early Diagnostic Pathology Test for Gastric Cancer Developed by University Of Georgia Researchers

New cancer test may be as easy as a home-use pregnancy test

Early detection of certain types of cancer may eventually become as easy as taking a home pregnancy test. That’s the prediction of researchers who are developing a non-invasive early diagnostic test for gastric cancer that would not require a pathologist  to assess a tissue specimen. Instead, this test detects biomarkers in the patient’s urine.

Surgical pathologists will recognize the potential of this discovery to create new tools for diagnosing cancer at earlier stages—and without the need to collect a tissue specimen. For clinical laboratories, the possibility of a urine-based test that could accurately detect different cancers would make it possible for them to offer diagnostic assays based on this technology to office-based physicians.

(more…)

New Study Finds that Hospitals with “Clout” Are Often Paid Higher Prices by Private Insurers

Some hospitals are paid as much as four times other hospitals in the same city for the same procedure

Across the clinical pathology laboratory testing industry, the use of deeply-discounted prices for medical laboratory tests has always been a flash point. But few consumers see the real price of the clinical laboratory test, and even many healthcare policy experts pay little attention to how clinical laboratories and pathology groups will set prices for laboratory tests.

That is not true of the prices hospitals charge. Because of sustained efforts by Medicare, private health insurers, and employers to make prices more transparent for patients, more information on the pricing policies of different hospitals is becoming available.

(more…)

;